V. Poletti (Forli, Italy), C. Robalo Cordeiro (Coimbra, Portugal)
The impact of age on broncholaveolar lavage (BAL) cytoimmunological results in nonsmoking patients with interstitial lung diseases (ILD) and in healthy volunteers
P. Kopinski, J. Szczeklik, B. Balicka-Slusarczyk, A. Dyczek, G. Przybylski, A. Rozy, J. Golinska, J. Chorostowska-Wynimko (Bydgoszcz, Krakow, Warszawa, Poland)
|   |
Effect of cigarette smoking on alveolar macrophages (AM) and lymphocytes (AL) apoptosis in selected interstitial lung diseases (ILD)
P. Kopinski, B. Balicka-Slusarczyk, G. Przybylski, A. Jarzemska, G. Pinis, J. Garlicki, M. Krawczyk, J. Szczeklik (Bydgoszcz, Krakow, Poland)
| |
Clinical implications of CCR5 expression and IL-2 secretion in bronchoalveolar lavage in hypersensitivity pneumonitis
J. Cemlyn-Jones, S. Freitas, T. M. Alfaro, A. Henriques, I. Silva, A. Paiva, L. Pais, C. Robalo Cordeiro (Coimbra, Portugal)
| |
Induced sputum in interstitial lung diseases; comparison with bronchial wash and BAL
B. Sahin, N. Aksel, A. Mertoglu, A. Ozsoz, N. Yucel (Izmir, Turkey)
| |
Induced sputum in nonsarcoid interstitial lung diseases; comparison with bronchial wash and BAL
B. Sahin, N. Aksel, A. Mertoglu, A. Ozsoz, N. Yucel (Izmir, Turkey)
| |
Induced sputum in patients with sarcoidosis; comparison with bronchial wash and bronchoalveolar lavage
B. Sahin, N. Aksel, A. Ozsoz, A. Mertoglu, N. Yucel (Izmir, Turkey)
| |
Alveolar epithelium in sarcoidosis (S) and hypersensitivity pneumonitis (HP)
Z. Kosjerina, V. Kosjerina Ostric (Sremska Kamenica, Serbia And Montenegro)
| |
The diagnostic value of the examination of the tumor markers CYFRA 21-1, NSE, TPA and CEA from the bronchoalveolar lavage fluid in diffuse pulmonary disorders
V. Lostakova, V. Kolek, M. Kapustova (Olomouc, Czech Republic)
| |
HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts
M. Faehling, D. Anders, M. Hetzel, V. Hombach, M. Bachem (Esslingen, Stuttgart, Ulm, Germany)
| |
Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression
B. Balicka-Slusarczyk, P. Kopinski, J. Chorostowska-Wynimko, K. Sladek, G. Pinis, J. Soja, J. Garlicki, K. Szablowska, A. Szpechcinski, J. Szczeklik (Krakow, Bydgoszcz, Warszawa, Poland)
| |
The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients
E. Bargagli, A. Mazzi, F. Mezzasalma, A. Perrone, P. Rottoli (Siena, Italy)
| |
Increased myeloid dendritic cells in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
M. Tsoumakidou, K. P. Karagiannis, N. Tzanakis, N. Siafakas (Heraklion, Greece)
| |
Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis is not associated with difference in expression of fas or fas ligand
F. Drakopanagiotakis, E. Tsiambas, V. Polychronopoulos, A. Karameris, D. Bouros (Athens, Alexandroupolis, Greece)
| |
Elevated percentage of hemosiderin-laden macrophages in the BAL fluid of patients with diffuse alveolar damage
F. Maldonado, J. Parambil, E. Yi, J. Ryu (Rochester, MN, Cleveland, OH, United States Of America)
| |
Increased Clara cell protein 16 levels in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
M. Tsoumakidou, I. Bouloukaki, K. Thimaki, N. Tzanakis, N. Siafakas (Heraklion, Greece)
| |
Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF
A. Cui, O. Anhenn, D. Theegarten, S. Ohshimo, F. Bonella, S. U. Sixt, J. Peters, J. Guzman, U. Costabel (Essen, Bochum, Germany)
| |
CXCR3 and CCR4 T cells in the follow-up of idiopathic pulmonary fibrosis patients
P. Pignatti, G. Moscato, M. Pisati, M. Vicari, A. Alessandrini, E. Rottoli, S. Nava, G. Brunetti (Pavia, Legnano, Italy)
| |
Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with interstitial lung diseases
F. Economidou, K. Antoniou, K. Samara, G. Soufla, C. Choulaki, A. Proklou, I. Politis, D. Moraitaki, N. Tzanakis, N. Siafakas (Heraklion, Greece)
| |
Correlation of cytokine gene polymorphisms and BALF cytokine levels in ILD
M. Vasakova, M. Sterclova, L. Kolesar, A. Slavcev, I. Striz, P. Pohunek, J. Sulc (Prague, Czech Republic)
| |
HRCT-score and markers of fibrosis in BAL in DPLD patients
A. Szlubowski, J. Soja, P. Grzanka, R. Tomaszewska, P. Kopinski, J. Kuzdzal, A. Cmiel, K. Sladek (Zakopane, Krakow, Bydgoszcz, Poland)
| |